Many cases of GIST show a clonal progression of disease with different nodules harbouring different KIT and PDGFRA mutations that confer an inter- and intra-lesional heterogeneity of drug resistance [32]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.